Skip to main content
. 2006 Jan 25;2006(1):CD003491. doi: 10.1002/14651858.CD003491.pub2

Eklund 1986.

Methods Double blind 
 RCT 
 Concealment of allocation ‐ unclear 
 Endpoint analysis 
 Active treatment 4 weeks
Participants Inclusion criteria: 
 17+ HMDR primary illness 
 Age: 60‐80 
 Country:Sweden 
 /Netherlands 
 Setting: unclear
Interventions Mianserin 
 versus 
 Imipramine
Outcomes Side effects 
 Drop out 
 HMD(21 item)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear